Settings
Light Theme
Dark Theme
Podcast Cover

Pediheart: Pediatric Cardiology Today

  • Pediheart Podcast #294: What Is The Evidence For Endocarditis Prophylaxis For Invasive Dental Procedures?

    26 APR 2024 · This week we delve into the world of antibiotic prophylaxis for dental procedures. What are the data to support its use in the congenital heart patient? Why has this been such a difficult topic to study? What do we now know about this topic and what still remains unanswered? Given the low prevalence but dire consequences of this disease, how can investigators consider studying this topic in the future? Is there adequate equipoise to proceed with a randomized controlled trial? We speak with Advanced Imaging Fellow at Boston Children's Hospital, Dr. Francesca Sperotto of Harvard University about her recent multicenter meta-analysis of 30 studies including over one million cases of endocarditis.  - DOI: https://doi.org/10.1001/jamacardio.2024.0873
    30m 45s
  • Pediheart Podcast #293: Sodium-Glucose Cotransporter 2 Inhibitors For ACHD Heart Failure

    19 APR 2024 · This week we review a recent work on the use of sodium-glucose cotransporter 2 inhibitors in the ACHD heart failure patient from Europe. Can these agents impact heart failure outcomes in this patient group? What is the mechanism by which they may improve outcomes? Are there data on their effects on the single ventricle patient? What sorts of side effects can be seen and are these more or less commonly observed in the ACHD patient? We speak with the corresponding author of this week's work, Dr. Anastasia Egorova of Leiden University in the Netherlands.  https://doi.org/10.1016/j.jacc.2024.02.017
    35m 26s
  • Pediheart Podcast #292: Impact Of Prenatal Diagnosis On 22q11 Deletion Syndrome Outcomes

    12 APR 2024 · This week we delve into the world of fetal cardiology when we review a recent large, multicenter study on the impact of prental diagnosis of 22.q11 deletion syndrome. How did the prenatally diagnosed patients differ from those diagnosed postnatally in regards to degree of heart disease and postnatal morbidity and mortality? What is the role of cell-free DNA testing in the screening for patients with this deletion syndrome? How do outcomes differ for this syndrome between the US and other countries and why might this be? These are amongst the many questions reviewed with the first author of this week's work, Dr. Lindsay Freud who is the director of fetal cardiology at Toronto Sick Kid's Hospital and also Associate Professor of Pediatrics at the University of Toronto.  Also joining the podcast this week are the co-directors of this year's Mount Sinai Imaging Symposium entitled: Conversations in Care - The Single Ventricle. Dr. David Ezon, Dr. Jennifer Cohen, Dr. Kenan Stern and Mount Sinai Technical Director and Echo Lab Manager, Ms. Jen Lie Yau share their thoughts about the upcoming conference. This year's symposium will be taking place on May 4th, 2024 and the faculty are a who's who of important pediatric cardiac specialists from the worlds of imaging, interventional cardiology, sonography, surgery and more.  For those interested, you can get more information about this wonderful conference at the following web address: https://mssm.cloud-cme.com/assets/MSSM/data/Single%20Ventricle%20Symposium24G.pdf Today's article link: - DOI: https://doi.org/10.1016/j.ajog.2023.09.005
    44m 59s
  • Pediheart Podcast #291: Reducing Cognitive Biases In Congenital Heart Decision Making

    5 APR 2024 · This week we delve into the world of cognitive bias when we review a recent review of this topic by the team at the University of Arkansas. What are some of the more important common cognitive biases that plague humans and are particularly deleterious for good decision making in 'case management/surgical' conference? What are some approaches to reducing the impact of these biases? How does the advent of ZOOM enhance or reduce bias for surgical conference decisions? We speak with noted authority on this topic, Dr. Joshua Daily who is Associate Professor of Pediatrics at The University of Arkansas in Little Rock for his deep insights into this topic.  https://doi.org/10.1007/s00246-024-03462-4 Other resources mentioned by Dr. Daily include: - Thinking Fast and Slow by Daniel Kahneman - Thinking In Bets by Annie Duke  - Predictably Irrational by Dan Ariely - How To Decide by Annie Duke
    39m 59s
  • Pediheart Podcast #290: Junctional Rhythm And The Fontan Patient

    29 MAR 2024 · This week we review a recent survey study on the topic of junctional rhythm and sinus node dysfunction in the Fontan. How important is this finding in our Fontan patients? When should a patient with a Fontan undergo pacemaker insertion? Is the loss of AV synchrony the more important hemodynamic effect of junctional rhythm or is it chronotropic incompetence? Who should be considered for a possible endocardial, transvenous atrial pacemaker in the Fontan patient? These are amongst the questions posed to this week's guest, noted pediatric electrophysiologist and Professor of Pediatrics at OHSU, Dr. Seshadri Balaji.  https://doi.org/10.1007/s00246-023-03296-6
    39m 4s
  • Pediheart Podcast #289: Transcatheter Edge-To-Edge AV Valve Repair In Congenital Heart Disease

    22 MAR 2024 · This week we delve into the world of interventional cardiology and the Fontan when we review a recent report from the Children's Hospital of Philadelphia on the use of the "MitraClip" for the treatment of AV valve regurgitation in the congenital heart patient. Who would be a good candidate for this novel approach? What are the steps in planning or consideration of this technique in a congenital heart patient? How durable is this form of repair? These are amongst the many questions reviewed this week with this week's senior author, Professor of Pediatrics at the Children's Hospital of Philadelphia, Dr. Matthew J. Gillespie.  - DOI: https://doi.org/10.1002/ccd.30935
    36m 24s
  • Pediheart Podcast Replay of #205: Cefazolin Dosing For Pediatric Cardiovascular Surgery

    15 MAR 2024 · This week we review an episode from 2022 in the world of cardiac surgery and pediatric pharmacology when we review a work from Australia on levels of cefazolin during and after surgery. Is there an optimal dose regimen that will achieve proper MIC levels of drug? What should the goal of therapy be in regards to MIC levels? Are there novel means of dosing cefazolin? We speak with pediatric critical care pharmacy coordinator at Mount Sinai Kravis Children's Hospital, Dr. Jessica Frye for the pharmacist's perspective on some of these important questions. https://doi.org/10.1016/j.athoracsur.2022.02.047
    26m 54s
  • Pediheart Podcast #288: Can An AI ECG Model Predict LV Dysfunction And Remodeling In Children?

    8 MAR 2024 · This week we review a recent work in the artificial intelligence/deep learning space when we review a recent report from the team at Boston Children's Hospital on a novel model trained to predict LV characteristics in children from the ECG. How does such a program identify LV dilation, dysfunction or hypertrophy from a test (the ECG) not designed to provide most of this information? How well did the model perform when it was tested in a different center entirely? Why is it important to understand how a model of this sort is making its determinations? How might such a model be used clinically? These are amongst the many questions reviewed with the work's first author, Dr. Joshua Mayourian MD, PhD who is a first year cardiology fellow at Boston Children's Hospital. https://doi.org/10.1161/circulationaha.123.067750
    47m 56s
  • Pediheart Podcast #287: Fontan Associated Liver Disease And Intrahepatic Transcriptomics

    1 MAR 2024 · This week we enter the world of the adult congenital heart patient when we discuss Fontan associated liver disease with an ACHD expert, Dr. Katia Bravo-Jaimes of the Mayo Clinic. In this episode we discuss the role of intrahepatic transcriptomics and how genetic analysis of liver biopsy tissue may provide new insights into the pathophysiology of this disease process. How can differential gene expression in the liver of Fontan patients help to explain why some patients have mild versus others severe fibrosis or even frank cirrhosis? Can these insights provide hope for improved surveillance or therapy for this problem? Dr. Bravo-Jaimes provides the answers this week. https://doi.org/10.1016/j.jacc.2023.12.005
    33m
  • Pediheart Podcast #287: Fontan Associated Liver Disease And Intrahepatic Transcriptomics

    1 MAR 2024 · This week we enter the world of the adult congenital heart patient when we discuss Fontan associated liver disease with an ACHD expert, Dr. Katia Bravo-Jaimes of the Mayo Clinic. In this episode we discuss the role of intrahepatic transcriptomics and how genetic analysis of liver biopsy tissue may provide new insights into the pathophysiology of this disease process. How can differential gene expression in the liver of Fontan patients help to explain why some patients have mild versus others severe fibrosis or even frank cirrhosis? Can these insights provide hope for improved surveillance or therapy for this problem? Dr. Bravo-Jaimes provides the answers this week. https://doi.org/10.1016/j.jacc.2023.12.005
    33m
A review of the latest literature and thought leaders in pediatric cardiovascular care.
Information
Author Robert Pass
Categories Health & Fitness
Website -
Email -

Looks like you don't have any active episode

Browse Spreaker Catalogue to discover great new content

Current

Looks like you don't have any episodes in your queue

Browse Spreaker Catalogue to discover great new content

Next Up

Episode Cover Episode Cover

It's so quiet here...

Time to discover new episodes!

Discover
Your Library
Search